Double-quencher probes improve detection sensitivity toward Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) in a reverse-transcription polymerase chain reaction (RT-PCR) assay

被引:44
作者
Hirotsu, Yosuke [1 ]
Mochizuki, Hitoshi [1 ,2 ]
Omata, Masao [2 ,3 ]
机构
[1] Yamanashi Cent Hosp, Genome Anal Ctr, 1-1-1 Fujimi, Kofu, Yamanashi, Japan
[2] Yamanashi Cent Hosp, Dept Gastroenterol, 1-1-1 Fujimi, Kofu, Yamanashi, Japan
[3] Univ Tokyo, Bunkyo Ku, 7-3-1 Hongo, Tokyo, Japan
基金
日本学术振兴会;
关键词
SARS-CoV-2; 2019-nCoV; COVID-19; RT-PCR; Quencher; Coronavirus; Diagnosis; INFECTION; DIAGNOSIS; COVID-19;
D O I
10.1016/j.jviromet.2020.113926
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Background: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) which emerged in the city of Wuhan, Hubei Province, China, has spread worldwide and is threatening human life. The detection of SARS-CoV-2 is critical for preventing new outbreaks, curbing disease spread, and managing patients. Currently, a reverse-transcription polymerase chain reaction (RT-PCR) assay is used to detect the virus in clinical laboratories. However, although this assay is considered to have high specificity, its sensitivity is reportedly as low as 60-70 %. Improved sensitivity is, therefore, urgently required. Methods: We used the primers and single-quencher probes recommended by the CDC (N1, N2 and N3) in the USA and the NIID (N1 and N2) in Japan. In addition, we designed double-quencher probes according to the virus sequence provided by the NIID to develop a further assay (termed the YCH assay [N1 and N2]). Using these assays, we conducted RT-PCR with serially diluted DNA positive controls to assess and compare the detection sensitivity of the three assays. Furthermore, 66 nasopharyngeal swabs were tested to determine the diagnostic performances. Results: The threshold cycle (Ct) value of the RT-PCR was relatively low for the CDC and YCH assays compared with the NIID assay. Serial dilution assays showed that both the CDC and YCH assays could detect low copy numbers of the DNA positive control. The background fluorescence signal at the baseline was lower for the YCH assay compared with the NIID assay. We assessed the diagnostic performance between single- (NIID) and double-quencher (YCH) probes using 66 nasopharyngeal swabs. When the results of YCH-N2 assay were used as a reference, each assay detected SARS-CoV-2 with positive percent agreements of 56 % for NIID-N1, 61 % for YCH-N1, and 94 % for NIID-N2, and 100 % negative percent agreements for NIID-N1, YCH-N1 and NIID-N2. Conclusion: Double-quencher probes decreased the background fluorescence and improved the detection sensitivity of RT-PCR for SARS-CoV-2.
引用
收藏
页数:6
相关论文
共 27 条
[1]   Correlation of Chest CT and RT-PCR Testing for Coronavirus Disease 2019 (COVID-19) in China: A Report of 1014 Cases [J].
Ai, Tao ;
Yang, Zhenlu ;
Hou, Hongyan ;
Zhan, Chenao ;
Chen, Chong ;
Lv, Wenzhi ;
Tao, Qian ;
Sun, Ziyong ;
Xia, Liming .
RADIOLOGY, 2020, 296 (02) :E32-E40
[2]   Diagnosis of SARS-CoV-2 infection based on CT scan vs RT-PCR: reflecting on experience from MERS-CoV [J].
Al-Tawfiq, J. A. ;
Memish, Z. A. .
JOURNAL OF HOSPITAL INFECTION, 2020, 105 (02) :154-155
[3]   2019-novel Coronavirus severe adult respiratory distress syndrome in two cases in Italy: An uncommon radiological presentation [J].
Albarello, Fabrizio ;
Pianura, Elisa ;
Di Stefano, Federica ;
Cristofaro, Massimo ;
Petrone, Ada ;
Marchioni, Luisa ;
Palazzolo, Claudia ;
Schinina, Vincenzo ;
Nicastri, Emanuele ;
Petrosillo, Nicola ;
Campioni, Paolo ;
Eskild, Petersen ;
Zumla, Alimuddin ;
Ippolito, Giuseppe .
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2020, 93 :192-197
[4]  
[Anonymous], 2020, Laboratory Testing for Coronavirus Disease (COVID-19) in Suspected Human Cases: Interim Guidance
[5]   COVID-19 in 2 Persons with Mild Upper Respiratory Symptoms on a Cruise Ship, Japan [J].
Arashiro, Takeshi ;
Furukawa, Keiichi ;
Nakamura, Akira .
EMERGING INFECTIOUS DISEASES, 2020, 26 (06) :1346-1348
[6]   Clinical Characteristics of Pregnant Women with Covid-19 in Wuhan, China [J].
Chen, Lian ;
Li, Qin ;
Zheng, Danni ;
Jiang, Hai ;
Wei, Yuan ;
Zou, Li ;
Feng, Ling ;
Xiong, Guoping ;
Sun, Guoqiang ;
Wang, Haibo ;
Zhao, Yangyu ;
Qiao, Jie .
NEW ENGLAND JOURNAL OF MEDICINE, 2020, 382 (25)
[7]   First case of Coronavirus Disease 2019 (COVID-19) pneumonia in Taiwan [J].
Cheng, Shao-Chung ;
Chang, Yuan-Chia ;
Chiang, Yu-Long Fan ;
Chien, Yu-Chan ;
Cheng, Mingte ;
Yang, Chin-Hua ;
Huang, Chia-Husn ;
Hsu, Yuan-Nian .
JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION, 2020, 119 (03) :747-751
[8]   Data, disease and diplomacy: GISAID's innovative contribution to global health [J].
Elbe, Stefan ;
Buckland-Merrett, Gemma .
GLOBAL CHALLENGES, 2017, 1 (01) :33-46
[9]   Sensitivity of Chest CT for COVID-19: Comparison to RT-PCR [J].
Fang, Yicheng ;
Zhang, Huangqi ;
Xie, Jicheng ;
Lin, Minjie ;
Ying, Lingjun ;
Pang, Peipei ;
Ji, Wenbin .
RADIOLOGY, 2020, 296 (02) :E115-E117
[10]   The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2 [J].
Gorbalenya, Alexander E. ;
Baker, Susan C. ;
Baric, Ralph S. ;
de Groot, Raoul J. ;
Drosten, Christian ;
Gulyaeva, Anastasia A. ;
Haagmans, Bart L. ;
Lauber, Chris ;
Leontovich, Andrey M. ;
Neuman, Benjamin W. ;
Penzar, Dmitry ;
Perlman, Stanley ;
Poon, Leo L. M. ;
Samborskiy, Dmitry V. ;
Sidorov, Igor A. ;
Sola, Isabel ;
Ziebuhr, John .
NATURE MICROBIOLOGY, 2020, 5 (04) :536-544